Top

Pediatric Cardiology

Published in:

01-08-2011 | Letter to the Editor

Secondary Prophylaxis is Important for the Prevention of Recurrent Rheumatic Fever in the Pacific

Authors: Andrew C. Steer, Samantha Colquhoun, Joseph Kado, Jonathan R. Carapetis

Published in: Pediatric Cardiology | Issue 6/2011

Excerpt

To the Editor: …

Anon (2006) National Heart Foundation of Australia (RF/RHD guideline development working group) and the Cardiac Society of Australia and New Zealand. Diagnosis and management of acute rheumatic fever and rheumatic heart disease in Australia—an evidence-based review

Bland EF, Jones TD (1951) Rheumatic fever and rheumatic heart disease. Circulation 4:836–843PubMed

Feinstein AR, Stern EK, Spagnuolo M (1964) The prognosis of acute rheumatic fever. Am Heart J 68:817–834PubMedCrossRef

Iyengar SD, Grover A, Kumar R, Ganguly NK, Anand IS et al (1991) A rheumatic fever and rheumatic heart disease control programme in a rural community of north India. Natl Med J India 4:268–271

Kumar R, Thakur JS, Aggarwal A, Ganguly NK (1997) Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India. Indian Heart J 49:282–288PubMed

Kuttner AG, Krumwiede E (1941) Observations on effect of streptococcal upper respiratory infections on rheumatic children: 3-year study. J Clin Invest 20:273–287PubMedCrossRef

Lue HC, Wu MH, Wang JK, Wu FF, Wu YN (1996) Three-versus four-week administration of benzathine penicillin G: effects on incidence of streptococcal infections and recurrences of rheumatic fever. Pediatrics 97:984–988PubMed

Majeed HA, Batnager S, Yousof AM, Khuffash F, Yusuf AR (1992) Acute rheumatic fever and the evolution of rheumatic heart disease: a prospective 12 year follow-up report. J Clin Epidemiol 45:871–875PubMedCrossRef

Manyemba J, Mayosi BM (2002) Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev (3): CD002227

10.

Rheumatic Fever Working Party (1965) The natural history of rheumatic fever and rheumatic heart disease: ten-year report of a cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation 32:457–476

11.

Sanyal SK, Berry AM, Duggal S, Hooja V, Ghosh S (1982) Sequelae of the initial attack of acute rheumatic fever in children from north India. A prospective 5-year follow-up study. Circulation 65:375–379PubMedCrossRef

12.

Seckeler MD, Barton LL, Brownstein R (2010) The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 14:e226–e229PubMedCrossRef

13.

Seckeler MD, Hoke TR, Gurka MJ, Barton LL (2010) No demonstrable effect of benzathine penicillin on recurrence of rheumatic fever in Pacific island population. Pediatr Cardiol 31:849–852PubMedCrossRef

14.

Steer AC, Carapetis JR (2009) Prevention and treatment of rheumatic heart disease in the developing world. Natl Rev Cardiol 6:689–698CrossRef

15.

Stollerman GH, Rusoff JH, Hirschfeld I (1955) Prophylaxis against group A streptococci in rheumatic fever; the use of single monthly injections of benzathine penicillin G. N Engl J Med 252:787–792PubMedCrossRef

16.

Talbot RG (1984) Rheumatic fever and rheumatic heart disease in the Hamilton health district: II. Long term follow-up and secondary prophylaxis. NZ Med J 97:634–637

17.

Tompkins DG, Boxerbaum B, Liebman J (1972) Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 45:543–551PubMed

18.

Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R (1964) Rheumatic fever in children and adolescents: a long-term epidemiological study of subsequent prophylaxis, streptococcal infections and clinical sequelae: III comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic fever recurrences. Ann Intern Med 60:31–46

Title: Secondary Prophylaxis is Important for the Prevention of Recurrent Rheumatic Fever in the Pacific
Authors: Andrew C. Steer
Samantha Colquhoun
Joseph Kado
Jonathan R. Carapetis
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: Pediatric Cardiology / Issue 6/2011
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-011-9966-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Secondary Prophylaxis is Important for the Prevention of Recurrent Rheumatic Fever in the Pacific

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

A Rare Congenital Aorto-Cardiac Fistula

From Other Journals

The Fontan Operation: The Pursuit of Associated Lesions and Cumulative Trauma

Usefulness of Fetal Three-Dimensional Ultrasonography for Detecting of Congenital Heart Defects and Associated Syndromes

Nonfluoroscopic and Radiation-Limited Ablation of Ventricular Arrhythmias in Children and Young Adults: A Case Series

Myocardial Perfusion and Exercise Capacity 12 Years After Arterial Switch Surgery for D-Transposition of the Great Arteries

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page